|
Alcami Corporation recently announced a new strategic partnership with Tanvex CDMO, a biologics developer offering pre-clinical to commercial biologic CDMO services. Through the collaboration, Alcami and Tanvex can now offer clients a complete solution from bulk drug substance production through to finished drug product, pairing Alcami’s expertise in liquid and lyophilization sterile filling, packaging, and labeling with Tanvex’s high-throughput bulk drug substance development and manufacturing services.
By adding Alcami’s breadth of sterile fill-finish capabilities and capacity,
» Read more about: Alcami Partners With Tanvex to Offer a Complete Solution for Biologics Developers »
|